lovastatin has been researched along with Atherogenesis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 18 (62.07) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Jiu, Q; Liu, B; Tang, D; Wang, G; Wang, Y; Wijaya, A; Wu, W; Yan, M; Zhong, Y | 1 |
| Shi, Y; Yan, M; Zhang, G; Zhang, L | 1 |
| Cicero, AFG; Fogacci, F; Stoian, AP; Toth, PP | 1 |
| He, J; Jiang, C; Liu, J; Yang, Y; Zhang, W; Zhao, Y | 1 |
| Guo, C; Jing, Y; Li, P; Li, QZ; Liu, Z; Lu, JX; Niu, HF; Ou, WS; Song, P; Xu, J; Yin, YL; Zhu, ML | 1 |
| Jia, H; Jiang, C; Li, Z; Liu, J; Qi, Z; Tang, Y; Zhang, W | 1 |
| Cao, J; Fu, X; Li, L; You, J; Zhang, Y | 1 |
| Bai, N; Cheng, JC; Francis, GA; Hiraiwa, K; Miyata, R; Sin, DD; Van Eeden, SF; Vincent, R | 1 |
| Alderson, P; Lewis, SR; Nicholson, A; Sanders, RD; Smith, AF | 1 |
| Baumgarten, G; Frede, S; Hilbert, T; Hoeft, A; Klaschik, S; Knuefermann, P; Poth, J | 1 |
| Fraemohs, L; Hackeng, TM; Koenen, RR; Schmitt, MM; Weber, C | 1 |
| He, H; Liu, J; Liu, L; Zhang, M; Zhang, S; Zhang, W | 2 |
| Calhoun, LN; DeBose-Boyd, RA; Engelking, L; Garland, K; Hartman, IZ; Hwang, S; McDonald, J; Mitsche, MA; Xu, F; Young, GA | 1 |
| Avello L, M; Bravo D, M; Calvo M, C; Mennickent C, S | 1 |
| Berkowitz, DE; Bhunia, A; Chang, F; Romer, LH; Ryoo, S; Shoukas, A | 1 |
| Buers, I; Engel, T; Hofnagel, O; Robenek, H; Severs, NJ | 1 |
| Choi, MS; Ha, TY; McGregor, RA; Shin, SK | 1 |
| Boettger, T; Boon, RA; Braun, T; Dimmeler, S; Frangakis, AS; Hergenreider, E; Heydt, S; Horrevoets, AJ; Mayr, M; Scheffer, MP; Tréguer, K; Urbich, C; Yin, X; Zeiher, AM | 1 |
| Ames, BD; Bruegger, J; Li, JW; Ma, S; Nguyen, C; Smith, P; Tang, Y; Tsai, SC; Vederas, JC; Wong, E; Wong, S; Xie, X; Xu, W | 1 |
| Lan, XH; Li, X; Xu, R; Zhou, YG | 1 |
| Hsu, YW; Hung, YP; Lee, CL; Pan, TM | 1 |
| Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Li, H; Nakabayashi, H; Nishi, S; Sakai, M; Zaman, TA | 1 |
| Rosenson, RS | 1 |
| Cannon, CP; Ray, KK | 1 |
| Crock, LW; Sethy-Coraci, I; Silverstein, SC | 1 |
| Hung, HK; Lee, CL; Pan, TM; Wang, JJ | 1 |
| Angri, V; Calabrò, P; Chiariello, M; Cirillo, P; De Rosa, S; Fiorentino, I; Gargiulo, A; Musto D'Amore, S; Pacileo, M; Petrillo, G; Prevete, N; Sasso, L; Ucci, G | 1 |
| Frisinghelli, A; Mafrici, A | 1 |
6 review(s) available for lovastatin and Atherogenesis
| Article | Year |
|---|---|
Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review.
Topics: Anticholesteremic Agents; Atherosclerosis; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Supplements; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Lovastatin | 2023 |
Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
Topics: Adult; Angioplasty; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Cause of Death; Cholestyramine Resin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Perioperative Care; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Sitosterols; Vascular Surgical Procedures | 2013 |
[Pleiotropic effects of statins].
Topics: Anticholesteremic Agents; Antioxidants; Atherosclerosis; Atorvastatin; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Oxidative Stress; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2008 |
Low high-density lipoprotein cholesterol disorders and cardiovascular risk: contribution of associated low-density lipoprotein subclass abnormalities.
Topics: Atherosclerosis; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins, LDL; Lovastatin; Risk Factors; Simvastatin | 2005 |
Optimal goals for statin use in patients with coronary artery disease.
Topics: Atherosclerosis; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Treatment Outcome | 2005 |
Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.
Topics: Adult; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Research Design; Risk Assessment; Risk Factors; Treatment Outcome | 2007 |
23 other study(ies) available for lovastatin and Atherogenesis
| Article | Year |
|---|---|
A study of lovastatin and L-arginine co-loaded PLGA nanomedicine for enhancing nitric oxide production and eNOS expression.
Topics: Animals; Arginine; Atherosclerosis; Cells, Cultured; Humans; Lovastatin; Male; Materials Testing; Mice; Mice, Inbred C57BL; Nanomedicine; Nitric Oxide; Nitric Oxide Synthase Type III; Polylactic Acid-Polyglycolic Acid Copolymer | 2022 |
Modulatory action of withaferin-A on oxidative damage through regulation of inflammatory mediators and apoptosis via PI3K/AKT signaling pathway in high cholesterol-induced atherosclerosis in experimental rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Atherosclerosis; Caspase 3; Cholesterol; Cytokines; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation Mediators; Lovastatin; Male; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; Signal Transduction | 2022 |
Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Cholesterol; Drug Carriers; Drug Combinations; Drug Compounding; Drug Synergism; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Mice; Nanoparticles; RAW 264.7 Cells; Recombinant Proteins | 2018 |
Citronellal prevents endothelial dysfunction and atherosclerosis in rats.
Topics: Acetylcholine; Acyclic Monoterpenes; Aldehydes; Animals; Anticholesteremic Agents; Aromatherapy; Atherosclerosis; Balloon Occlusion; Carotid Arteries; Cell Movement; Cholecalciferol; Diet, High-Fat; Endothelial Cells; Gene Expression; Humans; Lovastatin; Male; Oxidative Stress; Plaque, Atherosclerotic; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchanger 1; Vasodilation | 2019 |
Rational Design of Lovastatin-Loaded Spherical Reconstituted High Density Lipoprotein for Efficient and Safe Anti-Atherosclerotic Therapy.
Topics: Animals; Atherosclerosis; Cell Survival; Drug Carriers; Drug Compounding; Drug Synergism; Erythrocytes; Hemolysis; Lipoproteins, HDL; Lovastatin; Matrix Metalloproteinases; Mice; Mice, Knockout, ApoE; Nanospheres; Optical Imaging; Plaque, Atherosclerotic; Rabbits; RAW 264.7 Cells; Treatment Outcome | 2019 |
Effect of 7-difluoromethyl-5, 4'-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(-/-) mice induced by a cholesterol-rich diet.
Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Genistein; Hyperlipidemias; Lipids; Lovastatin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrites; Vasodilation; von Willebrand Factor | 2013 |
Statins attenuate the development of atherosclerosis and endothelial dysfunction induced by exposure to urban particulate matter (PM10).
Topics: Animals; Atherosclerosis; Blood Vessels; Cholesterol, Dietary; Cyclooxygenase 2; Cytokines; Endothelin-1; Endothelins; Endothelium, Vascular; Environmental Exposure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lipids; Lovastatin; Male; Nitric Oxide Synthase Type II; Particulate Matter; Plaque, Atherosclerotic; Rabbits; Reactive Oxygen Species; Urban Health; Vascular Diseases | 2013 |
Anti-atherogenic effects of statins: Impact on angiopoietin-2 release from endothelial cells.
Topics: Acyl Coenzyme A; Angiopoietin-2; Atherosclerosis; Cell Survival; Cells, Cultured; Endothelial Cells; Exocytosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Simvastatin; Weibel-Palade Bodies | 2013 |
Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution.
Topics: Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis; Cell Adhesion Molecules; Cells, Cultured; Coculture Techniques; Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Leukocyte Rolling; Leukocytes, Mononuclear; Lipoproteins, LDL; Lovastatin; Mice; Mice, Knockout; Permeability; Pioglitazone; Protein Transport; Receptors, Cell Surface; RNA Interference; Signal Transduction; Thiazolidinediones; Transendothelial and Transepithelial Migration; Transfection | 2014 |
Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions.
Topics: Animals; Aorta, Thoracic; Atherosclerosis; Disease Models, Animal; Drug Carriers; Fluorescent Antibody Technique; Hyaluronic Acid; Lipoproteins, HDL; Lovastatin; Macrophages; Male; Matrix Metalloproteinase 9; Nanostructures; Particle Size; Rabbits; Static Electricity; Tissue Distribution | 2014 |
Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.
Topics: Animals; Arachidonic Acid; Atherosclerosis; Cholesterol; Drug Carriers; Drug Delivery Systems; Lipoproteins, HDL; Lovastatin; Macrophages; Male; Matrix Metalloproteinase 9; Phosphatidylcholine-Sterol O-Acyltransferase; Rabbits | 2015 |
Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver.
Topics: Animals; Atherosclerosis; Cells, Cultured; Cholesterol; Hydroxymethylglutaryl CoA Reductases; Liver; Lovastatin; Mice; Mice, Knockout; Protein Structure, Tertiary; Proteolysis | 2016 |
OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.
Topics: Animals; Arginase; Atherosclerosis; Cells, Cultured; Cholesterol, Dietary; Endothelial Cells; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubules; Nitric Oxide; Protein Transport; rhoA GTP-Binding Protein; RNA Interference; Scavenger Receptors, Class E; Signal Transduction; Simvastatin; Superoxides; Transfection | 2011 |
SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Cell Adhesion; Cells, Cultured; Chemokine CXCL16; Chemokines, CXC; Coculture Techniques; Cytokines; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunohistochemistry; Inflammation Mediators; Lovastatin; Macrophages; Monocytes; Rabbits; Receptors, Scavenger; Thiazolidinediones | 2011 |
Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Curcumin; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Lipid Metabolism; Lipoproteins; Liver; Liver X Receptors; Lovastatin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Orphan Nuclear Receptors; PPAR alpha; Triglycerides; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2011 |
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Coculture Techniques; Endothelial Cells; Exosomes; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Kruppel-Like Transcription Factors; Lovastatin; Mice; Mice, Knockout; MicroRNAs; Microscopy, Confocal; Microscopy, Electron; Myocytes, Smooth Muscle; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stress, Mechanical; Transfection | 2012 |
Crystal structure and biochemical studies of the trans-acting polyketide enoyl reductase LovC from lovastatin biosynthesis.
Topics: Aspergillus; Atherosclerosis; Candida tropicalis; Catalytic Domain; Chromatography, Gel; Crystallography, X-Ray; Humans; Lovastatin; Molecular Conformation; Mutation; NADP; Polyketide Synthases; Protein Conformation; Protein Structure, Quaternary; Protein Structure, Tertiary; Static Electricity; Stereoisomerism; Substrate Specificity; Transcriptional Activation | 2012 |
[Effects of three different treatments on atherosclerosis and adipose in rats].
Topics: Adipose Tissue; Animals; Aspirin; Atherosclerosis; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Lovastatin; Male; Probucol; Rats; Rats, Sprague-Dawley | 2012 |
Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosages.
Topics: Animals; Aorta; Atherosclerosis; Creatine Kinase; Cricetinae; Flavins; Heterocyclic Compounds, 3-Ring; Lipid Peroxidation; Lipids; Liver Function Tests; Lovastatin; Male; Mesocricetus | 2013 |
Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
Topics: Animals; Atherosclerosis; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Protein-delta; Cell Line, Tumor; Cell Nucleus; Chromosome Mapping; Gene Expression; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Liver Neoplasms; Lovastatin; Mice; Mice, Inbred ICR; Mutagenesis, Site-Directed; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Response Elements; RNA, Messenger; Thrombosis; Transfection | 2005 |
PAF-receptor antagonists, lovastatin, and the PTK inhibitor genistein inhibit H2O2 secretion by macrophages cultured on oxidized-LDL matrices.
Topics: Atherosclerosis; Cells, Cultured; Extracellular Matrix; Genistein; Humans; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Macrophages; Phagocytes; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Receptors, G-Protein-Coupled; Time Factors | 2005 |
Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters.
Topics: Animals; Atherosclerosis; Cricetinae; Diet; Dioscorea; Fermentation; Hypolipidemic Agents; Lipids; Lovastatin; Male; Mesocricetus; Monascus; Oryza | 2007 |
HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
Topics: Atherosclerosis; Cell Adhesion; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endothelial Cells; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Intercellular Adhesion Molecule-1; Leukocytes; Lovastatin; NF-kappa B; Nicotine; Nicotinic Agonists; Pravastatin; Protein Kinase C; Reactive Oxygen Species; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Simvastatin; Smoking; Superoxide Dismutase; Time Factors; Vascular Cell Adhesion Molecule-1 | 2007 |